Gerresheimer AG
XETRA:GXI

Watchlist Manager
Gerresheimer AG Logo
Gerresheimer AG
XETRA:GXI
Watchlist
Price: 73.85 EUR 4.83% Market Closed
Market Cap: 2.6B EUR
Have any thoughts about
Gerresheimer AG?
Write Note

Gerresheimer AG
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gerresheimer AG
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Gerresheimer AG
XETRA:GXI
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Non-Reccuring Items
-€67.2m
CAGR 3-Years
-100%
CAGR 5-Years
-41%
CAGR 10-Years
-8%
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Non-Reccuring Items
€6.8m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Gerresheimer AG
Glance View

Market Cap
2.6B EUR
Industry
Life Sciences Tools & Services

Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 10,625 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.

GXI Intrinsic Value
161.9 EUR
Undervaluation 54%
Intrinsic Value
Price

See Also

Back to Top